Pages that link to "Q60176029"
Jump to navigation
Jump to search
The following pages link to C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy (Q60176029):
Displaying 31 items.
- Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease (Q34107573) (← links)
- Clinical Improvement in Psoriasis With Treatment of Associated Hyperlipidemia (Q34158912) (← links)
- Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives (Q34638027) (← links)
- Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities (Q34982043) (← links)
- G-231A and G 70C Polymorphisms of Endothelin Receptor Type-A Gene could Affect the Psoriasis Area and Severity Index Score and Endothelin 1 Levels (Q35215230) (← links)
- Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis (Q36124545) (← links)
- Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients (Q37554151) (← links)
- Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms (Q37673703) (← links)
- C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. (Q39201687) (← links)
- Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial (Q39803888) (← links)
- Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact? (Q41693144) (← links)
- Hit hard and early: Can the march of psoriasis be halted? (Q41848576) (← links)
- Associated comorbidities in psoriasis and inflammatory bowel disease (Q45907246) (← links)
- Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment (Q46180528) (← links)
- Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis (Q47606183) (← links)
- Factors associated with the length of remission of psoriasis vulgaris (Q47686097) (← links)
- Impaired coronary flow reserve in young patients affected by severe psoriasis (Q53094100) (← links)
- Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris. (Q54249692) (← links)
- The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. (Q54956609) (← links)
- Low Vitamin D in Psoriasis: Reality or Myth? (Q55280410) (← links)
- C677T Gene Polymorphism as Risk Factor for Psoriasis in Saudis (Q64107369) (← links)
- Evaluation of serum adenosine deaminase and inflammatory markers in psoriatic patients (Q64289124) (← links)
- Association between psoriasis and chronic obstructive pulmonary disease: a population‐based study in Taiwan (Q83571747) (← links)
- Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab (Q83687527) (← links)
- Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients (Q84443500) (← links)
- Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese (Q84578288) (← links)
- Assessment of left atrial volume and function in patients with psoriasis by using real time three-dimensional echocardiography (Q85681378) (← links)
- Evaluation of systemic oxidant/antioxidant status and paraoxonase 1 enzyme activities in psoriatic patients treated by narrow band ultraviolet B phototherapy (Q85712901) (← links)
- Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients? (Q91905971) (← links)
- Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis (Q92338380) (← links)
- Evaluation of carotid intima media thickness and hematologic inflammatory markers in patients with chronic spontaneous urticaria (Q96134715) (← links)